Minaris Regenerative Medicine GmbH (früher apceth Biopharma GmbH)
Biotechnology, Medical Technology
-
Short facts
- Year founded 2007
- 137 Employees (site)
- Turnover: not available
Products/services: Creating Cell Therapy Miracles Together Minaris Regenerative Medicine is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics. The company has a comprehensive expertise in GMP manufacturing of autologous and allogeneic cell types that are either native or genetically modified. It has long-standing experience with various cell products, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSC), lymphocytes, monocytes, dendritic cells, cord blood derived stem cells, and has the potential to expand to CAR-T and induced pluripotent stem cell (iPSC) technologies. apceth has successfully obtained manufacturing licenses for multiple cell therapy products for clinical as well as commercial use. Creating Cell Therapy Miracles Together Minaris Regenerative Medicine is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics. The company has a comprehensive expertise in GMP manufacturing of autologous and allogeneic cell types that are either native or genetically modified. It has long-standing experience with various cell products, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSC), lymphocytes, monocytes, dendritic cells, cord blood derived stem cells, and has the potential to expand to CAR-T and… read more
Basic data
Company
Minaris Regenerative Medicine GmbH (früher apceth Biopharma GmbH)
Street
Haidgraben 5
PC / City
85521 Ottobrunn
County
Upper Bavaria
Phone
+49 89 7009608-0
Homepage
Language skills
English, German
Contact person
Sales / marketing: Dr. Almut Windhager (Mrs.)
Management: Dusan Kosijer (Mr.)
Profile/competences
Core competencies
CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION (CDMO)
•Reliable, experienced and high-performance partner for our clients
•Complex cell-based and gene therapy products (ATMPs)
•Pioneer in the development of cell-based gene therapies
•Clinical and commercial GMP manufacturing
•Process, product and assay development
•GMP-certified since 2010
Key sectors / sub-sectors
- Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
- Biotechnology: Tissue engineering and regenerative medicine
- Medical Technology: Implants, biomaterials, tissue engineering
NACE industries
- Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
- Manufacture of pharmaceutical preparations 21.2
- Manufacture of pharmaceutical preparations 21.20
- Scientific research and development 72
- Research and experimental development on natural sciences and engineering 72.1
- Research and experimental development on biotechnology 72.11
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available